227 related articles for article (PubMed ID: 1370773)
21. Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals.
Calarota S; Jansson M; Levi M; Broliden K; Libonatti O; Wigzell H; Wahren B
AIDS Res Hum Retroviruses; 1996 May; 12(8):705-13. PubMed ID: 8744581
[TBL] [Abstract][Full Text] [Related]
22. Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses.
Brown LE; White DO; Agius C; Kemp BE; Yatzakis N; Poumbourios P; McPhee DA; Jackson DC
Arch Virol; 1995; 140(4):635-54. PubMed ID: 7540829
[TBL] [Abstract][Full Text] [Related]
23. Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding.
Binley JM; Ditzel HJ; Barbas CF; Sullivan N; Sodroski J; Parren PW; Burton DR
AIDS Res Hum Retroviruses; 1996 Jul; 12(10):911-24. PubMed ID: 8798976
[TBL] [Abstract][Full Text] [Related]
24. Collection of phage-peptide probes for HIV-1 immunodominant loop-epitope.
Palacios-Rodríguez Y; Gazarian T; Rowley M; Majluf-Cruz A; Gazarian K
J Microbiol Methods; 2007 Feb; 68(2):225-35. PubMed ID: 17046088
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China.
Li X; Wu Y; Ren X; Deng S; Hu G; Yu S; Tang S
PLoS One; 2016; 11(11):e0165874. PubMed ID: 27802337
[TBL] [Abstract][Full Text] [Related]
26. Role of preimmunization virus sequences in cellular immunity in HIV-infected patients during HIV type 1 MN recombinant gp160 immunization.
Kundu SK; Dupuis M; Sette A; Celis E; Dorner F; Eibl M; Merigan TC
AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1669-78. PubMed ID: 9870321
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
[TBL] [Abstract][Full Text] [Related]
28. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection.
Eberle J; Loussert-Ajaka I; Brust S; Zekeng L; Hauser PH; Kaptue L; Knapp S; Damond F; Saragosti S; Simon F; Gürtler LG
J Virol Methods; 1997 Aug; 67(1):85-91. PubMed ID: 9274821
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and immunological characterization of a 134-mer synthetic peptide corresponding to the N-terminal half of the HIV-1 nucleoprotein, p24.
Chong P; Sia C; Tam E; Kandil A; Klein M
Int J Pept Protein Res; 1993 Jan; 41(1):21-7. PubMed ID: 7679666
[TBL] [Abstract][Full Text] [Related]
30. T cell recognition of HIV synthetic peptides in a natural infection.
Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
[TBL] [Abstract][Full Text] [Related]
31. B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus.
Schrier RD; Gnann JW; Langlois AJ; Shriver K; Nelson JA; Oldstone MB
J Virol; 1988 Aug; 62(8):2531-6. PubMed ID: 3260630
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 peptides induce a proliferative response in lymphocytes from infected persons.
Wahren B; Rosen J; Sandström E; Mathiesen T; Modrow S; Wigzell H
J Acquir Immune Defic Syndr (1988); 1989; 2(5):448-56. PubMed ID: 2552068
[TBL] [Abstract][Full Text] [Related]
33. Binding behaviour of antibodies reacting specifically with an immunodominant region of the transmembrane protein gp41 of HIV-1.
Döpel SH; Porstmann T; Grunow R; Henklein P; Pas P; von Baehr R
J Virol Methods; 1990 May; 28(2):189-98. PubMed ID: 1695222
[TBL] [Abstract][Full Text] [Related]
34. Systematic identification of T-cell activating epitopes on the human immunodeficiency virus type 1 envelope glycoprotein gp120 in primates immunized with synthetic peptides.
Eriksson K; Horal P; Svennerholm B; Jeansson S; Vahlne A; Holmgen J; Czerkinsky C
Vaccine; 1993; 11(8):859-65. PubMed ID: 7689284
[TBL] [Abstract][Full Text] [Related]
35. Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants.
Gu R; Stagnar C; Zaichenko L; Ramsingh AI
Vaccine; 2012 May; 30(24):3666-74. PubMed ID: 22464964
[TBL] [Abstract][Full Text] [Related]
36. B cell antigenic site mapping of HIV-1 glycoproteins.
Neurath AR
Chem Immunol; 1993; 56():34-60. PubMed ID: 8452653
[No Abstract] [Full Text] [Related]
37. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
38. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
[TBL] [Abstract][Full Text] [Related]
39. An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement.
Eaton AM; Ugen KE; Weiner DB; Wildes T; Levy JA
AIDS Res Hum Retroviruses; 1994 Jan; 10(1):13-8. PubMed ID: 7514015
[TBL] [Abstract][Full Text] [Related]
40. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.
Boots LJ; McKenna PM; Arnold BA; Keller PM; Gorny MK; Zolla-Pazner S; Robinson JE; Conley AJ
AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1549-59. PubMed ID: 9430247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
